- Additional Authors
- Description
- 16 p. : digital, PDF file.
- Alternative Title
- E14 clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs
- Clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs
- Subject
- Note
- Title from PDF title page (viewed on June 18, 2009).
- "ICH".
- "October 2005".
- System Details (note)
- Mode of access: Internet at the FDA web site. Address as of 6/18/09: http://www.fda.gov/downloads/RegulatoryInformation/Guidances/ucm129357.pdf ; current access is available via PURL.
- Call Number
- GPO Internet HE 20.4702:C 61
- OCLC
- 402662444
- Title
Guidance for industry [electronic resource] : E14 clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs.
- Imprint
Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research, [2005]
- System Details
Mode of access: Internet at the FDA web site. Address as of 6/18/09: http://www.fda.gov/downloads/RegulatoryInformation/Guidances/ucm129357.pdf ; current access is available via PURL.
- Connect to:
- Added Author
Center for Drug Evaluation and Research (U.S.)
Center for Biologics Evaluation and Research (U.S.)
International Conference on Harmonisation.
- Gpo Item No.
0499-T (online)
- Sudoc No.
HE 20.4702:C 61
- Research Call Number
GPO Internet HE 20.4702:C 61